Boland M, Higgins A, Beecher C, et al. Identifying priorities for future research on reducing and stopping psychiatric medication: results of a James Lind Alliance priority-setting partnership. BMJ Open 2024;14:e088266. doi: 10.1136/bmjopen-2024-088266
Brandt J, Bressi J, Lê M-L, et al. Prescribing and deprescribing guidance for benzodiazepine and benzodiazepine receptor agonist use in adults with depression, anxiety, and insomnia: An international scoping review. eClinicalMedicine. 2024;70:102507. doi:10.1016/j.eclinm.2024.102507
Lynch T, Ryan C, Huff C, Foster DE, Cadogan C. ‘We need more support and doctors that understand the process of tapering …’: A content analysis of free‐text responses to a questionnaire on discontinuing long‐term benzodiazepine receptor agonist use. Health Expectations. 2024;27(1).
Ritvo AD, Foster DE, Huff C, Finlayson AJR, Silvernail B, et al. (2023) Long-term consequences of benzodiazepine-induced neurological dysfunction: A survey. PLOS ONE 18(6): e0285584.
Huff, C., Finlayson, A. R., Foster, D. E., & Martin, P. R. (2023). Enduring neurological sequelae of benzodiazepine use: an Internet survey. Therapeutic Advances in Psychopharmacology, 13, 20451253221145561.
Lynch, T., Ryan, C., Bradley, C., Foster, D., Huff, C., Hutchinson, S., … & Cadogan, C. (2022). Supporting safe and gradual reduction of long‐term benzodiazepine receptor agonist use: Development of the SAFEGUARDING‐BZRAs toolkit using a codesign approach. Health Expectations, 25(4), 1904-1918.
Reid Finlayson, A. J., Macoubrie, J., Huff, C., Foster, D. E., & Martin, P. R. (2022). Experiences with benzodiazepine use, tapering, and discontinuation: an Internet survey. Therapeutic Advances in Psychopharmacology, 12, 20451253221082386.
Huff, C., (2021). Response to “Acute and Persistent Withdrawal Syndromes following Discontinuation of Psychotropic Medications” by Cosci et al. (2020). Psychother Psychosom 2021;90:207-208. doi: 10.1159/000514045
Horowitz, M. A., Wright, J. M., & Taylor, D. (2021). Risks and benefits of benzodiazepines. JAMA, 325(21), 2208. https://doi.org/10.1001/jama.2021.4513
Witt-Doerring, J., Shorter, D., & Kosten, T. R. (2018, April 18). Online Communities for Drug Withdrawal: What Can We Learn? Psychiatric Times.
Kaufmann CN, Spira AP, Depp CA, et Long-term use of benzodiazepines and nonbenzodiazepine hypnotics from 1999-2014: results from the National Health and Nutrition Examination Survey. Psychiatr Serv. 2018;69(2):235-8. Article
Benítez CI, Smith K, Vasile RG, et Use of benzodiazepines and selective serotonin reuptake inhibitors in middle-aged and older adults with anxiety disorders: a longitudinal and prospective study. Am J Geriatr Psychiatry.2008;16(1):5-13. Abstract
Rickels K, Schweizer E, Case WG, Greenblatt Long-term therapeutic use of benzodiazepines. I. Effects of abrupt discontinuation. Arch Gen Psychiatry. 1990;47(10):899-907. Abstract
Tyrer Benzodiazepine dependence: a shadowy diagnosis. Biochem Soc Symp. 1993;59:107-119. Abstract
Fixsen AM, Ridge Stories of hell and healing: internet users’ construction of benzodiazepine distress and withdrawal. Qual Health Res. 2017;27(13):2030-41. Abstract
Fava Fading of therapeutic effects of alprazolam in agoraphobia. Case reports. Prog Neuropsychopharmacol Biol Psychiatry. 1988;12(1):109-12. Abstract
Pélissolo A, Maniere F, Boutges B, et Anxiety and depressive disorders in 4,425 long term benzodiazepine users in general practice. Encephale. 2007;33(1):32-8. Abstract
Pollmann AS, Murphy AL, Bergman JC, et . Deprescribing benzodiazepines and Z-drugs in community-dwelling adults: a scoping review. BMC Pharmacol Toxicol. 2015;16(1):1-12. Article
Kaiser Permanente. Benzodiazepine and Z-Drug Safety Guideline. Published January 2019. Accessed April 27,2021. https://wa.kaiserpermanente.org/static/pdf/public/guidelines/benzo-zdrug.pdf
Dodds Prescribed Benzodiazepines and Suicide Risk: A Review of the Literature. Prim Care Companion CNS Disord. 2017;19(2). Article
Belleville Mortality hazard associated with anxiolytic and hypnotic drug use in the National Population Health Survey. Can J Psychiatry. 2010;55(9):558-567. Abstract
Xu KY, Hartz SM, Borodovsky JT, Bierut LJ, Grucza Association Between Benzodiazepine Use With or Without Opioid Use and All-Cause Mortality in the United States, 1999-2015. JAMA Netw Open.2020;3(12):e2028557. Article
Chen LH, Hedegaard H, Warner Drug-poisoning Deaths Involving Opioid Analgesics: United States, 1999-2011. NCHS Data Brief. 2014;(166):1-8. Article
Brubacher JR, Chan H, Erdelyi S, Zed PJ, Staples JA, Etminan Medications and risk of motor vehicle collision responsibility in British Columbia, Canada: a population-based case-control study [published online ahead of print, 2021 Apr 19]. Lancet Public Health. 2021;S2468-2667(21)00027-X. Article
Dassanayake T, Michie P, Carter G, Jones Effects of benzodiazepines, antidepressants and opioids on driving: a systematic review and meta-analysis of epidemiological and experimental evidence. Drug Saf. 2011;34(2):125-56. Abstract
Gunja In the Zzz zone: the effects of Z-drugs on human performance and driving. J Med Toxicol. 2013;9(2):163-71. Article
Pariente A, Dartigues JF, Benichou J, et Benzodiazepines and injurious falls in community dwelling elders. Drugs Aging.2008;25(1):61-70. Abstract
LaCorte How chronic administration of benzodiazepines leads to unexplained chronic illnesses: A hypothesis. Med Hypotheses. 2018;118:59-67. Abstract
Rickels K, Freeman Prior benzodiazepine exposure and benzodiazepine treatment outcome. J Clin Psychiatry. 2000;61(6):409-13. Abstract
Rickels K, Schweizer E, Csanalosi I, et al. Long-term treatment of anxiety and risk of Prospective comparison of clorazepate and buspirone. Arch Gen Psychiatry. 1988;45(5):444-50. Abstract
Stephens A glutamatergic hypothesis of drug dependence: extrapolations from benzodiazepine receptor ligands. Behav Pharmacol. 1995;6(5 And 6):425-46. Abstract
Linsky A, Simon SR, Bokhour B. Patient perceptions of proactive medication Patient Educ Couns.2015;98(2):220-5. Abstract
Charles C, Gafni A, Whelan Shared decision-making in the medical encounter: what does it mean? (or it takes at least two to tango). Soc Sci Med. 1997;44(5):681-92. Abstract
Rabi DM, Kunneman M, Montori When guidelines recommend shared decision-making. JAMA. 2020;323(14):1345-6. Article
Tannenbaum C, Martin P, Tamblyn R, et Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the EMPOWER cluster randomized trial. JAMA Intern Med.2014;174(6):890-8. Article
Allison C, Pratt Neuroadaptive processes in GABAergic and glutamatergic systems in benzodiazepine dependence. Pharm Ther. 2003;98(3):171-95. Abstract
Horowitz MA, Taylor Tapering of SSRI treatment to mitigate withdrawal symptoms. Lancet Psychiatry. 2019;6(6):538-546. Abstract
Golomb BA, McGraw JJ, Evans MA, et Physician response to patient reports of adverse drug effects: implications for patient- targeted adverse effect surveillance. Drug Saf. 2007;30(8):669-75. Abstract
McConnell Benzodiazepine tolerance, dependency, and withdrawal syndromes and interactions with fluoroquinolone antimicrobials. Br J Gen Pract. 2008;58(550):365-6. Article
Cikkek Malcolm Lader professzortól (a lista korántsem teljes):
Discontinuation symptoms in depression and anxiety disorders (2007) DOI: 10.1017/S1461145705006358
Effectiveness of benzodiazepines: do they work or not? (2008) DOI: 10.1586/14737175.8.8.1189
Withdrawing benzodiazepines in primary care (2009) DOI: 10.2165/0023210-200923010-00002
Usage of benzodiazepines: A review (2009) DOI: 10.3109/13651500903447810
Benzodiazepines revisited--will we ever learn? (2011) DOI: 10.1111/j.1360-0443.2011.03563.x
Benzodiazepine harm: how can it be reduced? (2014) DOI: 10.1111/j.1365-2125.2012.04418.x
Cikkek Heather Ashton Professzortól (nem teljes lista)
Benzodiazepine withdrawal: an unfinished story (1984) DOI: 10.1136/bmj.288.6424.1135
Benzodiazepine withdrawal: outcome in 50 patients (1987) DOI: 10.1111/j.1360-0443.1987.tb01529.x
Risks of dependence on benzodiazepine drugs: a major problem of long term treatment (1989) DOI: 10.1136/bmj.298.6666.103
Protracted withdrawal syndromes from benzodiazepines (1991) DOI: 10.1016/0740-5472(91)90023-4
Guidelines for the rational use of benzodiazepines. When and what to use (1994) DOI: 10.2165/00003495-199448010-00004
The diagnosis and management of benzodiazepine dependence (2005) DOI: 10.1097/01.yco.0000165594.60434.84
Review: brief interventions, gradual dose reduction and psychological interventions increase benzodiazepine cessation compared with routine care (2009) DOI: 10.1136/ebmh.12.3.91
A double-blind placebo-controlled study of buspirone in diazepam withdrawal in chronic benzodiazepine users (2018) DOI: 10.1192/bjp.157.2.232
